Disruptive Technologies in Pharma
Industry Analytical Framework
The Analytical Framework of disruptive technologies in pharma is a comprehensive methodology developed by the Deep Knowledge Group to analyze and assess the impact of disruptive technologies on the pharmaceutical industry. The framework is designed to evaluate the industry across various dimensions, including technological advances, regulatory frameworks, investment and funding, market demand and adoption, and societal impact.
The framework considers a range of factors and indicators within each of these dimensions, such as the adoption and integration of emerging technologies like artificial intelligence, blockchain, and gene editing, the level of regulation and compliance, the availability of funding and investment, and the potential impact on society and the economy.
Access Deep Pharma Intelligence Big Data Analytics Dashboard
AI for Drug Discovery Industry Analytical Framework formed the basis of the Deep Pharma Intelligence Big Data Analytics Dashboard, tracking the status of 700 companies, 1,400 investors, 260 collaborations, various clinical trials, publications, news, and a large amount of other valuable information. This delivers advanced market intelligence, interactive mindmaps, benchmarking for companies, investors, and technologies, competitive and SWOT analysis.
